JP2010529205A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529205A5
JP2010529205A5 JP2010512324A JP2010512324A JP2010529205A5 JP 2010529205 A5 JP2010529205 A5 JP 2010529205A5 JP 2010512324 A JP2010512324 A JP 2010512324A JP 2010512324 A JP2010512324 A JP 2010512324A JP 2010529205 A5 JP2010529205 A5 JP 2010529205A5
Authority
JP
Japan
Prior art keywords
use according
therapeutic agent
pharmaceutical composition
calcium channel
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010512324A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529205A (ja
JP5576790B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066576 external-priority patent/WO2008154585A1/en
Publication of JP2010529205A publication Critical patent/JP2010529205A/ja
Publication of JP2010529205A5 publication Critical patent/JP2010529205A5/ja
Application granted granted Critical
Publication of JP5576790B2 publication Critical patent/JP5576790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010512324A 2007-06-11 2008-06-11 脳血管れん縮の予防用薬物送達システム Expired - Fee Related JP5576790B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94312407P 2007-06-11 2007-06-11
US60/943,124 2007-06-11
US97690207P 2007-10-29 2007-10-29
US60/976,902 2007-10-29
PCT/US2008/066576 WO2008154585A1 (en) 2007-06-11 2008-06-11 A drug delivery system for the prevention of cerebral vasospasm

Publications (3)

Publication Number Publication Date
JP2010529205A JP2010529205A (ja) 2010-08-26
JP2010529205A5 true JP2010529205A5 (enExample) 2011-07-28
JP5576790B2 JP5576790B2 (ja) 2014-08-20

Family

ID=40096090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010512324A Expired - Fee Related JP5576790B2 (ja) 2007-06-11 2008-06-11 脳血管れん縮の予防用薬物送達システム

Country Status (10)

Country Link
US (2) US8303974B2 (enExample)
EP (1) EP2164497B1 (enExample)
JP (1) JP5576790B2 (enExample)
KR (3) KR101554258B1 (enExample)
CN (3) CN105055300A (enExample)
AU (1) AU2008261668C1 (enExample)
CA (1) CA2690600C (enExample)
IL (1) IL202647A (enExample)
NZ (2) NZ599430A (enExample)
WO (1) WO2008154585A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
CN105055300A (zh) * 2007-06-11 2015-11-18 R·骆克·麦克唐纳 用于预防脑血管痉挛的药物递送系统
EP2308478A1 (en) 2009-10-06 2011-04-13 Abbott GmbH & Co. KG Delivery system for sustained release of a calcium-channel blocking agent
CN106913874A (zh) * 2010-02-22 2017-07-04 优势医疗公司 治疗脑的出血性病状的方法和组合物
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
WO2012051116A1 (en) 2010-10-12 2012-04-19 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2672983B1 (en) 2011-02-11 2017-04-19 Edge Therapeutics, Inc. Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage
WO2012138854A1 (en) * 2011-04-05 2012-10-11 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
CN102416013A (zh) * 2011-12-30 2012-04-18 湖南九典制药有限公司 西尼地平的新用途
US9399019B2 (en) * 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
WO2014165023A1 (en) 2013-03-12 2014-10-09 Carnegie Mellon University Coated vaso-occclusive device for treatment of aneurysms
CN103211812A (zh) * 2013-04-02 2013-07-24 苏州大学附属第一医院 Skf96365在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
US10403395B2 (en) * 2013-10-14 2019-09-03 SecondOpinionExpert, Inc. Method and apparatus for generating objective medical second opinion
WO2016122791A1 (en) * 2015-01-30 2016-08-04 The Regents Of The University Of California Spinal subpial gene delivery system
US20160346224A1 (en) * 2015-05-29 2016-12-01 Edge Therapeutics, Inc. Compositions and methods for reducing visual loss
MX2018001507A (es) 2015-08-03 2018-09-18 Enb Therapeutics Llc Composiciones y metodos para tratar cánceres asociados con la activacion del etbr.
CA3069159A1 (en) 2017-07-11 2019-01-17 Sustained Nano Systems Llc Hypercompressed pharmaceutical formulations
CN111886010A (zh) 2018-01-12 2020-11-03 Enb治疗公司 用于治疗与etbr激活相关的癌症的氘化化合物、组合物和方法
US20200163947A1 (en) * 2018-11-02 2020-05-28 Nortic Holdings Inc. Methods of treatment using nimodipine parenteral formulations
US20200315547A1 (en) * 2019-04-02 2020-10-08 Tencent America LLC Vertebral artery dissection risk evaluation method, computer device, and storage medium
US11103142B2 (en) 2019-04-02 2021-08-31 Tencent America LLC System and method for predicting vertebral artery dissection
JP7716076B2 (ja) * 2021-02-04 2025-07-31 学校法人産業医科大学 血管内穿孔によるくも膜下出血モデルの血腫を可視化する方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
JPH09507487A (ja) 1994-01-05 1997-07-29 アーキュール，インコーポレーテッド 選ばれた性質を有するアミンイミドおよびオキサゾロンをベースとした分子の系統的モジュール製造
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
JP2909418B2 (ja) * 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
US5977163A (en) 1996-03-12 1999-11-02 Pg-Txl Company, L. P. Water soluble paclitaxel prodrugs
WO1999002139A1 (en) 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
US20030032676A1 (en) * 2001-08-09 2003-02-13 Kimelberg Harold K. Drugs for treatment of cerebral injury and methods of use thereof
US20040224030A1 (en) * 2003-05-06 2004-11-11 Shastri Venkatram R. Microsphere delivery systems
AU2004259209A1 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
CN1480128A (zh) * 2003-08-06 2004-03-10 北京扬新科技有限公司 一种透明、隐形的外用药物制剂
US20050069591A1 (en) * 2003-09-30 2005-03-31 Howard Bernstein Injectable, oral, or topical sustained release pharmaceutical formulations
US20060205733A1 (en) 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
US7829527B2 (en) * 2005-02-02 2010-11-09 University Of Vermont And State Agricultural College Emergence of a R-type Ca2+ channel (Cav 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
US20060217340A1 (en) 2005-03-23 2006-09-28 University Of Vermont And State Agricultural College Methods and products for treating hypertension by modulation of TRPC3 channel activity
CN105055300A (zh) * 2007-06-11 2015-11-18 R·骆克·麦克唐纳 用于预防脑血管痉挛的药物递送系统

Similar Documents

Publication Publication Date Title
TWI750218B (zh) sGC 刺激劑
TWI373335B (en) Pharmaceutical composition for therapeutic treatment of arteriosclerosi and hypertension
JP5450434B2 (ja) 関節炎の治療方法
WO2000018352A2 (en) A method for treating inflammatory diseases by administering a thrombin inhibitor
TW200829244A (en) Therapeutic combinations 482
JP2008508279A5 (enExample)
KR20170055531A (ko) 에스지씨 자극제
AU2017216429A1 (en) Use of sGC stimulators for the treatment of Nonalcoholic Steatohepatitis (NASH)
CN115068468B (zh) 作为缓激肽b1受体拮抗剂的羧酸芳族酰胺
TWI344467B (en) Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
JP2018510916A (ja) 医薬処方物
KR20130129906A (ko) 시그마 수용체-매개 장애를 치료하기 위한 시클릭 아미드 유도체의 사용 방법
EP1061908A1 (en) Combination therapy and composition for acute coronary ischemic syndrome and related conditions
JP2013525460A5 (enExample)
EP1699461A1 (en) Treatment of hepatic fibrosis with imatinib mesylate
JP2006096665A (ja) 脊柱管狭窄症治療剤
JP6934859B2 (ja) 腎疾患の治療のための医薬
TW201000097A (en) Medicament for the prophylaxis or treament of hypertension
JPWO2015012205A1 (ja) 高血圧症の予防又は治療のための医薬
KR20060130619A (ko) 유기 화합물의 조합물
EP1813282A4 (en) MEANS FOR THE TREATMENT OF ANGIOSPASM IN SUBARACHO-OAL BLOODING WITH THROMBIN RECEPTOR ANTAGONIST AS AN ACTIVE AGENT
CA2709103A1 (en) Method and composition for treating an alpha adrenoceptor-mediated condition
AU2006263120B2 (en) Herpesvirus-derived therapeutic agent for pain
CN1809353B (zh) 一种预防和治疗动脉硬化及高血压的药剂
CA2671891C (en) V3 antagonists for the treatment or prevention of chronic pain